Arrieta A et al. |
High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506028
|
Maves RC et al. |
Antimicrobial susceptibility of Brucella melitensis isolates in Peru. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21199926
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Salman S et al. |
Pharmacokinetic properties of azithromycin in pregnancy. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19858250
|
Nalca Y et al. |
Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16641435
|
Asgrimsson V et al. |
Novel effects of azithromycin on tight junction proteins in human airway epithelia. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16641453
|
Chave JP et al. |
Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324635
|
Derouin F et al. |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324642
|
Dubois J et al. |
In vitro and intracellular activities of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila isolates. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25348534
|
Dagan R et al. |
Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602721
|
Clark C et al. |
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183253
|
Blandizzi C et al. |
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11959610
|
Moon JE et al. |
Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723556
|
Steele-Moore L et al. |
In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10383373
|
Matsui H et al. |
Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica serovar typhimurium. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16048953
|
Carannante A et al. |
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25070110
|
Zhang Y et al. |
Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27855081
|
Waites KB et al. |
In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27855075
|
Scorneaux B et al. |
Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8723471
|
Shimuta K et al. |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23939890
|
Babl FE et al. |
Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placebo. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12069974
|
D'Ignazio J et al. |
Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16189077
|
Tissi L et al. |
In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8540695
|
Jensen JS et al. |
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24637681
|
Bielaszewska M et al. |
Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22391549
|
Nagai K et al. |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600391
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Andersen SL et al. |
Efficacy of azithromycin as a causal prophylactic agent against murine malaria. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986022
|
Niki Y et al. |
In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840560
|
Welsh LE et al. |
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1318677
|
Freeman CD et al. |
Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7840585
|
Nagai K et al. |
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796375
|
Goldstein EJ et al. |
Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7625795
|
Sjölund-Karlsson M et al. |
Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21690279
|
Ramya TN et al. |
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060533
|
Su XH et al. |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914). |
2015 |
Antimicrob. Agents Chemother. |
pmid:26482313
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Rakita RM et al. |
Intracellular activity of azithromycin against bacterial enteric pathogens. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7810998
|
Imamura Y et al. |
Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15793115
|
Shima K et al. |
Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21321137
|
Chinh NT et al. |
Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21730120
|
Ma Q et al. |
A Waterborne Outbreak of Shigella sonnei with Resistance to Azithromycin and Third-Generation Cephalosporins in China in 2015. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28373192
|
Wind CM et al. |
A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28373191
|
Karlowsky JA et al. |
Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12760850
|
Yamaguchi H et al. |
Chlamydia pneumoniae resists antibiotics in lymphocytes. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12760877
|
Kutlin A et al. |
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11796350
|
Waites KB et al. |
In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25824220
|
Matzneller P et al. |
Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23357769
|
Lee N et al. |
Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial. |
2017 |
Antiviral Res. |
pmid:28535933
|
Allen G |
Evidence appraisal of Tita ATN, Szychowski JM, Boggess K, et al. Adjunctive azithromycin prophylaxis for cesarean delivery.: N Engl J Med. 2016;375:1231-1241. |
2017 |
AORN J |
pmid:28034388
|